Omeprazole and Paroxysmal supraventricular tachycardia - a phase IV clinical study of FDA data
Summary:
We study 380,957 people who have side effects when taking Omeprazole. Paroxysmal supraventricular tachycardia is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Aspirin and have Pain.
The phase IV clinical study analyzes which people take Omeprazole and have Paroxysmal supraventricular tachycardia. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
380,957 people reported to have side effects when taking Omeprazole.
Among them, 528 people (0.14%) have Paroxysmal supraventricular tachycardia.
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is used in gastroesophageal reflux disease. Currently, eHealthMe is studying from 390,286 Omeprazole users.
What is Paroxysmal supraventricular tachycardia?
Paroxysmal supraventricular tachycardia is found to be associated with 2,211 drugs and 1,793 conditions by eHealthMe. Currently, we are studying 16,641 people who have Paroxysmal supraventricular tachycardia.
Number of Omeprazole and Paroxysmal supraventricular tachycardia reports submitted per year:
Time on Omeprazole when people have Paroxysmal supraventricular tachycardia *:
Gender of people who have Paroxysmal supraventricular tachycardia when taking Omeprazole*:
Age of people who have Paroxysmal supraventricular tachycardia when taking Omeprazole *:
Common drugs people take besides Omeprazole *:
Common side effects people have besides Paroxysmal supraventricular tachycardia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Omeprazole and have Paroxysmal supraventricular tachycardia?
Check whether Paroxysmal supraventricular tachycardia is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Omeprazole side effects by duration, gender and age:
- Omeprazole side effects (390,286 reports)
Paroxysmal supraventricular tachycardia treatments and more:
- Paroxysmal supraventricular tachycardia (16,641 reports)
Common drugs associated with Paroxysmal supraventricular tachycardia:
- Aspirin: 915 reports
- Prednisone: 653 reports
- Omeprazole: 528 reports
- Digoxin: 500 reports
- Furosemide: 478 reports
- Lasix: 468 reports
- Metformin: 430 reports
- Lisinopril: 407 reports
- Vioxx: 380 reports
- Amlodipine: 365 reports
All the drugs that are associated with Paroxysmal supraventricular tachycardia:
- Paroxysmal supraventricular tachycardia (2,211 drugs)
Common conditions associated with Paroxysmal supraventricular tachycardia:
- High blood pressure: 570 reports
- Diabetes: 369 reports
- Osteoporosis: 363 reports
- Rheumatoid arthritis: 355 reports
- Pain: 339 reports
- Primary pulmonary hypertension: 332 reports
All the conditions that are associated with Paroxysmal supraventricular tachycardia:
- Paroxysmal supraventricular tachycardia (1,793 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Caffeine Citrate and Neonatal Hypoxia - 22 seconds ago
- Folic Acid and Paleness - 53 seconds ago
- Fish Oil and Pepcid Ac drug interaction - 57 seconds ago
- Vimpat and Obsessive-Compulsive Disorder - 59 seconds ago
- Pepcid Ac and Aciphex drug interaction - a minute ago
- Depakote and Extrapyramidal Disorder - a minute ago
- Methylprednisolone and Effexor Xr drug interaction - 2 minutes ago
- Norflex and Erection Problems - 2 minutes ago
- Glycine and Folic Acid drug interaction - 3 minutes ago
- Pantothenate and Neck Pain - 3 minutes ago